[go: up one dir, main page]

NO20014507D0 - Legemiddel for behandling av sukkersyke - Google Patents

Legemiddel for behandling av sukkersyke

Info

Publication number
NO20014507D0
NO20014507D0 NO20014507A NO20014507A NO20014507D0 NO 20014507 D0 NO20014507 D0 NO 20014507D0 NO 20014507 A NO20014507 A NO 20014507A NO 20014507 A NO20014507 A NO 20014507A NO 20014507 D0 NO20014507 D0 NO 20014507D0
Authority
NO
Norway
Prior art keywords
treatment
enzyme mixtures
pancreatin
diabetes
digestive enzyme
Prior art date
Application number
NO20014507A
Other languages
English (en)
Other versions
NO20014507L (no
Inventor
Suntje Sander-Struckmeier
Claus Rudolf Steinborn
Martin A Rudmann
Diethard Schwanitz
Friederike Henniges
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO20014507L publication Critical patent/NO20014507L/no
Publication of NO20014507D0 publication Critical patent/NO20014507D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20014507A 1999-03-17 2001-09-17 Legemiddel for behandling av sukkersyke NO20014507D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19911778 1999-03-17
PCT/EP2000/002261 WO2000054799A2 (de) 1999-03-17 2000-03-15 Arzneimittel zur behandlung von diabetes

Publications (2)

Publication Number Publication Date
NO20014507L NO20014507L (no) 2001-09-17
NO20014507D0 true NO20014507D0 (no) 2001-09-17

Family

ID=7901217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014507A NO20014507D0 (no) 1999-03-17 2001-09-17 Legemiddel for behandling av sukkersyke

Country Status (23)

Country Link
US (1) US7122357B2 (no)
EP (1) EP1162995B1 (no)
JP (1) JP4938174B2 (no)
CN (1) CN1221284C (no)
AT (1) ATE242003T1 (no)
AU (1) AU773930B2 (no)
BR (1) BR0009012A (no)
CA (1) CA2367355C (no)
CZ (1) CZ20013345A3 (no)
DE (2) DE50002450D1 (no)
DK (1) DK1162995T3 (no)
ES (1) ES2194720T3 (no)
HK (1) HK1044477B (no)
HU (1) HUP0200556A3 (no)
NO (1) NO20014507D0 (no)
NZ (1) NZ514826A (no)
PL (1) PL199180B1 (no)
PT (1) PT1162995E (no)
RU (1) RU2268065C2 (no)
SK (1) SK284677B6 (no)
TR (1) TR200102784T2 (no)
WO (1) WO2000054799A2 (no)
ZA (1) ZA200107110B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20013345A3 (cs) * 1999-03-17 2002-01-16 Solvay Pharmaceuticals Gmbh Léčivo k léčení diabetu
US7020384B1 (en) 1999-08-12 2006-03-28 Lg Electronics Inc. Method for creating and recording transport time information for data recorded on a disk
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8100844B2 (en) * 2002-04-25 2012-01-24 Ultraflex Systems, Inc. Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
US7519274B2 (en) 2003-12-08 2009-04-14 Divx, Inc. File format for multiple track digital data
PT1729797E (pt) 2004-03-22 2008-12-17 Solvay Pharm Gmbh Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos
JP2008500055A (ja) * 2004-05-24 2008-01-10 ノボザイムス アクティーゼルスカブ 医薬用途のための酵素
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
NZ563777A (en) * 2005-06-24 2010-08-27 Novozymes As Serine protease derived from Bacillus licheniformis optionally in combination with lipases and amylases for pharmaceutical use
CA2612648A1 (en) * 2005-06-24 2006-12-28 Novozymes A/S Lipases for pharmaceutical use
NZ563737A (en) * 2005-06-24 2010-08-27 Novozymes As Amylases derived from Bacillus stearothermophilus optionally in combination with proteases and/or lipases for pharmaceutical use
CA2616943C (en) * 2005-07-29 2016-04-12 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
PT1931316E (pt) 2005-08-15 2010-03-29 Solvay Pharm Gmbh Composições farmacêuticas de libertação controlada para fármacos instáveis em ácido
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
CN101242812B (zh) * 2005-08-15 2012-12-26 雅培产品有限公司 适合肠溶包衣的胰酶微丸芯
RU2408364C2 (ru) * 2005-08-15 2011-01-10 Зольвай Фармасьютиклз Гмбх Ядра микропеллет панкреатина, пригодные для нанесения энтеросолюбильного покрытия
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
CN105112386A (zh) 2006-12-21 2015-12-02 诺维信公司 用于药物用途的脂肪酶变体
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
MX2010005690A (es) 2007-12-04 2010-06-08 Novozymes As Variantes de proteasa para uso farmaceutico.
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
GB2465814B (en) * 2008-06-19 2011-10-26 Tarig Sayed Mustafa Arbab Method,composition and device for the treatment of enzymes and saccharides disorders
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
ES2727746T3 (es) 2009-01-06 2019-10-18 Galenagen Llc Composiciones orales para el tratamiento o la prevención de infecciones por E. Coli
ES2578618T3 (es) 2009-01-06 2016-07-28 Curelon Llc Composiciones que comprenden proteasa, amilasa y lipasa para su uso en el tratamiento de infecciones por Staphylococcus aureus
RU2400245C1 (ru) * 2009-04-02 2010-09-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Средство для контроля уровня гликемии и профилактики сосудистых осложнений у больных с нарушениями углеводного обмена и сахарным диабетом типа 2
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
WO2011140106A1 (en) * 2010-05-03 2011-11-10 Eurand Pharmaceuticals Limited Micropellet compositions comprising pancreatin containing digestive enzyme mixtures
MX347770B (es) 2011-04-21 2017-05-12 Curemark Llc Compuesto para el tratamiento de alteraciones neuropsiquiatricas.
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
US20130273026A1 (en) * 2012-04-12 2013-10-17 Integrative Enzymatics, Inc. Composition and method for modulating inflammatory molecules with amylase
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
AU2018250823A1 (en) 2017-04-10 2019-10-17 Curemark, Llc Compositions for treating addiction
EP3685661A4 (en) * 2017-09-19 2021-05-19 Meiji University Method for developing organ lacking specific functional cell
CN109142728A (zh) * 2018-09-04 2019-01-04 深圳市鸿美诊断技术有限公司 一种定量测定粪便中胰弹性蛋白酶1的试剂盒及其应用
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803305A (en) * 1962-12-28 1974-04-09 Rolland A Lab Process for obtaining extracts from pancreas
DE2512746C3 (de) 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin
SU908352A1 (ru) * 1980-02-11 1982-02-28 Винницкий Областной Госпиталь Для Инвалидов Отечественной Войны Способ лечени гнойных ран
DE4203315A1 (de) 1991-02-14 1992-08-20 Kali Chemie Pharma Gmbh Verfahren zur gewinnung von pankreatin
US5614224A (en) * 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics
CZ20013345A3 (cs) * 1999-03-17 2002-01-16 Solvay Pharmaceuticals Gmbh Léčivo k léčení diabetu

Also Published As

Publication number Publication date
CN1221284C (zh) 2005-10-05
WO2000054799A2 (de) 2000-09-21
CA2367355A1 (en) 2000-09-21
JP2002539173A (ja) 2002-11-19
PT1162995E (pt) 2003-08-29
DE50002450D1 (de) 2003-07-10
HUP0200556A2 (en) 2002-06-29
WO2000054799A3 (de) 2001-04-26
HK1044477A1 (en) 2002-10-25
US20020061302A1 (en) 2002-05-23
HK1044477B (zh) 2006-02-03
SK284677B6 (sk) 2005-09-08
DK1162995T3 (da) 2003-06-23
NZ514826A (en) 2003-08-29
SK12852001A3 (sk) 2002-02-05
AU4395000A (en) 2000-10-04
BR0009012A (pt) 2001-12-26
PL350627A1 (en) 2003-01-27
NO20014507L (no) 2001-09-17
ES2194720T3 (es) 2003-12-01
RU2268065C2 (ru) 2006-01-20
CA2367355C (en) 2012-06-05
EP1162995B1 (de) 2003-06-04
PL199180B1 (pl) 2008-08-29
CZ20013345A3 (cs) 2002-01-16
ATE242003T1 (de) 2003-06-15
DE10012095A1 (de) 2000-09-21
HUP0200556A3 (en) 2006-06-28
TR200102784T2 (tr) 2002-04-22
AU773930B2 (en) 2004-06-10
EP1162995A2 (de) 2001-12-19
CN1343126A (zh) 2002-04-03
US7122357B2 (en) 2006-10-17
JP4938174B2 (ja) 2012-05-23
ZA200107110B (en) 2002-10-30

Similar Documents

Publication Publication Date Title
NO20014507L (no) Legemiddel for behandling av sukkersyke
RU2001126526A (ru) Лекарственное средство, предназначенное для лечения диабета
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
JP2002539173A5 (no)
HUP0500560A2 (hu) Mikróbás enzimek új keverékei
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
SE0001899D0 (sv) New compounds
MXPA06001173A (es) Metodo analitico para la pancreatina y composiciones comparables.
MXPA03006364A (es) TRATAMIENTO DE PERTURBACIONES DEL SUEnO.
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
AU2001272735A1 (en) Novel physiologically active peptide and use thereof
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
CA2549185A1 (en) Peptide inhibiting angiotensin converting enzyme
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
TR200101980T2 (tr) Arilalkanoil türevleri, bunların preparasyon işlemleri
ZA200209714B (en) Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV.
DE69727268D1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
WO2003011119A3 (en) Methods and compositions for diagnosis and treatment of vascular conditions
YU31902A (sh) Polipeptidna kompozicija
RU2004119893A (ru) Лекарственное средство гастропек для лечения и профилактики нарушений процессов пищеварения и способ его применения
TW200512193A (en) Pyridinyl carbamates

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application